Role of heme oxygenase/carbon monoxide pathway on the vascular response to noradrenaline in portal hypertensive rats

Clinical and Experimental Pharmacology and Physiology

Volumn 32, Issue 3, 2005, Pages 196-201

  Erario, M A ^a   Gonzales, S ^a   Romay, S ^a   Eizayaga, F X ^a   Castro, J L ^a   Lemberg, A ^a   Tomaro, Maria L ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Carbon monoxide; Heme oxygenase; Noradrenaline; Portal hypertension; Rats

Indexed keywords

CARBON MONOXIDE; HEME OXYGENASE; HEME OXYGENASE 1; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN; PROTOPORPHYRIN ZINC; UNCLASSIFIED DRUG; ZINC PROTOPORPHYRIN IX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HYPEREMIA; IN VIVO STUDY; LIVER CIRRHOSIS; LIVER HOMOGENATE; MEAN ARTERIAL PRESSURE; MESENTERIC ARTERY; NONHUMAN; PORTAL HYPERTENSION; PROTEIN EXPRESSION; RAT; SPLANCHNIC BLOOD FLOW; SPLEEN;

ANIMALS; BLOOD PRESSURE; CARBON MONOXIDE; FEMALE; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HYPERTENSION, PORTAL; NITRIC OXIDE; NOREPINEPHRINE; RATS; RATS, WISTAR; VASOCONSTRICTOR AGENTS;

EID: 15244347186     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2005.04171.x     Document Type: Article

References (31)

1. Bosch J, Pizcueta P, Feu F, Fernandez M, Garcia-Pagan JC. Pathophysiology of portal hypertension. Gastroenterol. Clin. North Am. 1992; 21: 1-13.
2. Garcia-Pagan JC, Fernandez M, Bernadich C et al. Effects of continued nitric oxide inhibition on portal hypertensive syndrome after portal vein stenosis in rat. Am. J. Physiol. 1994; 267: G984-90.
3. Fernandez M, Garcia-Pagan JC, Casadevall M et al. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal hypertensive rats. Gastroenterology 1995; 108: 1487-95.
4. Cahill PA, Redmond EM, Hodges R, Zhang S, Sitzmann JV. Increased endothelial nitric oxide synthase activity in the hyperemic vessels of portal hypertensive rats. J. Hepatol. 1996; 25: 370-8.
5. Fernandez M, Garcia-Pagan JC, Casadevall M et al. Acute and chronic cyclooxigenase blockade in portal hypertensive rats: Influence on nitric oxide biosynthesis. Gastroenterology 1996; 110: 1529-35.
6. Lee FY, Albillos A, Colombatto L, Groszmann RJ. The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats. Hepatology 1992; 16: 1043-8.
7. Sieber CC, Groszmann RJ. Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vesells of portal hypertensive rats. Gastroenterology 1992; 103: 235-9.
8. Heinemann A, Wachter CH, Fickert P, Stauber RE. Nitric oxide-dependent and -independent vascular hyporeactivity in mesenteric arteries of portal hypertensive rats. Br. J. Pharmacol. 1997; 121: 1031-7.
9. Romay S, Eizayaga FX, Castro JL, Ricci D, Lemberg A. Endothelin-3 and norepinephrine: Effects on prehepatic portal-hypertensive rats. Pharmacol. Rev. Commun. 1997; 9: 279-86.
10. Maines MD. Heme oxygenase: Function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J. 1988; 2: 2557-68.
11. Maines MD, Traskhel GM, Kutty RK. Characterization of two constitutive forms of rat microsomal heme oxygenase: Only one molecular species of the enzyme is inducible. J. Biol. Chem. 1986; 261: 411-19.
12. Tomaro ML, Batlle AMC. Bilirubin: Its role in cytoprotection against oxidative stress. Int. J. Biochem. Cell Biol. 2002; 34: 216-20.
13. Ryter SW, Tyrrell RM. The heme synthesis and degradation pathways: Role in oxidant sensitivity. Free Radic. Biol. Med. 2000; 28: 289-309.
14. Ignarro LJ, Napoli C, Loscalzo J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: An overview. Circ. Res. 2002; 90: 21-8.
15. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991; 43: 109-42.
16. Maines MD. The heme oxygenase system: A regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 1997; 37: 517-54.
17. Utz J, Ullrich V. Carbon monoxide relaxes ileal smooth muscle through activation of guanylate cyclase. Biochem. Pharmacol. 1991; 41: 1195-201.
18. Wiest R, Shah V, Sessa WC, Groszmann RJ. NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats. Am. J. Physiol. 1999; 276: G1043-51.
19. Vorobioff J, Bredfeldt JE, Groszmann RJ. Hyperdynamic circulation in a portal hypertensive rat model: A primary factor for maintenance of chronic portal hypertension. Am. J. Physiol. 1983; 244: G52-7.
20. Llesuy SF, Tomaro ML. Heme oxygenase and oxidative stress. Evidence of involvement of bilirubin as physiological protector against oxidative damage. Biochim. Biophys. Acta 1994; 1223: 9-14.
21. Foresti R, Clark JE, Green CJ, Motterlini R. Thiol compounds interact with nitric oxide in regulating heme oxygenase-1 induction in endothelial cells. J. Biol. Chem. 1997; 272: 18 411-17.
22. Lowry HO, Rosebrough NJ, Fair AL, Randall RJ. Protein measurement with the Folin reagent. J. Biol. Chem. 1951; 193: 265-75.
23. Chojkier M, Groszmann RJ. Measurement of portal-systemic shunting in the rat by using gamma-labeled microspheres. Am. J. Physiol. 1991; 240: G371-5.
24. Fernandez M, Lambrecht RW, Bonkovsky HL. Increased heme oxygenase activity in splanchnic organs from portal hypertensive rats: Role in modulating mesenteric vascular reactivity. J. Hepatol. 2001; 34: 812-17.
25. Pizcueta P, Pique JM, Fernandez M et al. Modulation of the hyper-dynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology 1992; 103: 1909-15.
26. Wiest R, Groszmann RJ. Nitric oxide and portal hypertension: Its role in the regulation of intrahepatic and splanchnic vascular resistence. Semin. Liver Dis. 1999; 19: 411-25.
27. Huang HC, Wang SS, Chan CC et al. Chronic inhibition of nitric oxide increases the collateral vascular responsiveness to vasopressin in portal hypertensive rats. J. Hepatol. 2004; 40: 234-8.
28. Makino N, Suematsu M, Sugiura Y et al. Altered expression of heme oxygenase-1 in the livers of patients with portal hypertensive diseases. Hepatology 2001; 33: 32-42.
29. Motterlini R, Gonzales A, Foresti R, Clark JE, Green CJ, Winslow RM. Heme oxygenase-1-derived carbon monoxide contributes to the suppression of acute hypertensive response in vivo. Circ. Res. 1998; 83: 568-77.
30. Suematsu M, Susuki H, Delano FA, Schmid-Schönbein GW. The inflammatory aspect of the microcirculation in hypertension: Oxidative stress, leukocytes/endothelial interactions, apoptosis. Microcirculation 2002; 9: 259-76.
31. Fernandez M, Bonkovsky HL. Increased heme oxygenase-1 gene expression in liver cells and splanchnic organs from portal hypertensive rats. Hepatology 1999; 29: 1672-9.